三生国健: 三生国健药业（上海）股份有限公司董事、高级管理人员所持本公司股份及其变动管理制度

General Principles - The management system for the shares held by the directors and senior management of the company is established to strengthen the management of shareholding and its changes, in accordance with relevant laws and regulations [1][2] - This system applies to the shares held by the company's directors and senior management, including shares registered in their names and those held through others' accounts [2] Prohibited Share Transfer Conditions - Directors and senior management are prohibited from transferring shares under certain conditions, such as within one year of the company's stock listing or within six months after leaving the company [2][3] - Additional prohibitions include situations involving investigations by regulatory authorities or administrative penalties related to securities violations [2] Trading Restrictions - Directors and senior management cannot trade company shares during specific periods, including 15 days before the announcement of annual or semi-annual reports and 5 days before quarterly reports [3] - They must also ensure that close relatives and controlled entities do not trade based on insider information [4] Reporting and Disclosure Requirements - Directors and senior management must report their shareholding changes within two trading days through the company to the Shanghai Stock Exchange, detailing the number of shares before and after the change, the date, price, and reason for the change [7][8] - A reduction plan must be reported 15 trading days in advance, including details such as the number of shares to be reduced and the reasons for the reduction [8] Compliance and Accountability - The company’s board secretary is responsible for managing the identity and shareholding data of directors and senior management, ensuring compliance with reporting requirements [9] - If the board fails to comply with regulations, shareholders have the right to demand action or take legal action [5][6]